SOT ToxExpo 2024

PointCross was present at the 2024 SOT #ToxExpo.

Date: March 10–14, 2024

Salt Palace Convention Center
in downtown Salt Lake City, Utah

Takeaways:

CROs and Sponsors love PointCross’ instant SEND quote generator, fast turnaround time, and study data visualization offering
Integrating bioanalytical and complex biomarker data with as collected in-life data can be done in real time and people loved seeing subject level study details for ongoing study monitoring!

Mitigating risk with PointCross

As some may have heard, the FDA released their bi-annual update to the Technical Conformance Guide earlier this year. Along with slight corrections and improvements, an entire Appendix was added regarding SEND data review "Best Practices". With the update, the...

June 9, 2026

Categorized NON CLINICAL PointCross Blog

5 SEND Compliance Challenges Nonclinical CROs Must Solve

This article breaks down the real SEND compliance challenges that nonclinical CROs face, grounded in current FDA and CDISC requirements, and shows where disciplined process and the right tooling change the outcome. We write this for toxicologists, regulatory affairs professionals,...

June 8, 2026

The Business Case for Automating Nonclinical Study Reports

Categorized NON CLINICAL PointCross Blog

The Business Case for Automating Nonclinical Study Reports

The study report and its SEND dataset are built twice from the same data. Automating nonclinical study reports deletes that duplication, cuts cost 30 to 50 percent, and removes the inconsistencies that trigger FDA queries.

June 3, 2026

Mitigating risk with PointCross

5 SEND Compliance Challenges Nonclinical CROs Must Solve

The Business Case for Automating Nonclinical Study Reports

FDA SEND Requirements for Nonclinical Studies: Which Studies Need SEND Datasets in 2026?